Published: 2021-08-27

Male breast cancer: a 5-year experience from a State Cancer Institute

Shashi Singh Pawar, Manish Kumar, Kunal Kishor, Nadeem Ahmad, Sanjeet Kumar Singh, Kumari Anshu Lata


Background: Male breast cancer (MBC) is an uncommon malignancy accounting for <1% of all cancers in men and <1 % of overall breast cancer cases. Although there are many similarities between MBC and female breast cancer (FBC), they are not identical in clinical behaviour. There is need to understand the exact biological behavior of MBC.

Methods: A retrospective observational study was done at State Cancer Institute, IGIMS, Patna which included all MBC patients registered during a 5-year study period (January 2016 to April 2021). 16 consecutive cases of MBC were identified and their detailed clinicopathological profile was analyzed.

Results: MBC accounted for 1.10% of the total breast cancer cases. The median age of presentation was 58 years. Most common presentation was lump. Invasive ductal carcinoma (IDC) was most common histology. Majority of the patient presented to us in advanced stage. Estrogen receptor (ER)/progesterone receptor (PR) status was found to be positive in 12 patients. HER-2/neu receptor was positive in 4 patients. 2 patients had triple negative disease (TNBC) status. Surgery in the form of modified radical mastectomy (MRM) was done in 10 patients. All patients received adjuvant therapy as per NCCN guidelines.

Conclusions: MBC is rare disease presenting at a relatively early age in Indian male patients. Most of them have positive ER/PR status. As outcomes have not improved comparatively, there is a need to evolve separate guidelines for MBC.


Male breast cancer, Female breast cancer, State cancer institute

Full Text:



Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006;367:595-604.

Anderson WF, Jatoi I, Tse J, PSR. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010;28:232-9.

Cardoso F, Bartlett JMS, Slaets L. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Ann Oncol. 2018;29(2):405-17.

Korde LA, Zujewski JA, Kamin L. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010;28(12):2114-22.

Miao H, Verkooijen HM, Chia KS. Incidence and outcome of male breast cancer: an international population-based study. J Clin Oncol. 2011;29(33):4381-6.

Liu N, Johnson KJ, Ma CX. Male breast cancer: an updated surveillance, epidemiology, and end results data analysis. Clin Breast Cancer. 2018;18(5):e997-1002.

Chhabra MK, Kadyaprath G. Male Breast Cancer-an Indian Multicenter Series of 106 Cases. Indian J Surg. 2019.

Shah P, Robbani I, Shah O. Clinicopathological study of male breast carcinoma: 24 years of experience. Ann Saudi Med. 2009;29(4):288-93.

Shukla NK, Seenu V, Goel AK, Raina V, Rath GK, Singh R. Male breast cancer: a retrospective study from a regional cancer center in northern India. J Surg Oncol. 1996;61:143-8.

Ghoshal S, Rai B, Sharma SC. Breast cancer in males: a PGIMER experience. J Cancer Res Ther. 2005;1:31-3.

Gogia A, Raina V, Deo S. Male breast cancer: a single institute experience. Indian J Cancer. 2015;52:526.

Chikaraddi S, Krishnappa R, Deshmane V. Male breast cancer in Indian patients: is it the same? Indian J Cancer. 2012;49:272.

Mukherjee A, Saha A, Chattopadhyay S, Sur PK. Clinical trends and outcomes of male breast cancer: experience of a tertiary oncology centre in India Original Article Abstract. Int J Cancer Ther Oncol. 2014;2:1-8.

Sundriyal D, Kotwal S, Dawar R, Parthasarathy KM. Male breast cancer in India: series from a cancer research centre. Indian J Surg Oncol. 2015;6:384-6.

Patel R, Kumar R, Pandya SJ, Mendiratta P. Male breast cancer: single institutional experience at Gujarat Cancer &Research institute. Int J Curr Adv Res. 2016;5:1203-4.

Ram D, Rajappa SK, Selvakumar VP, Shukla H, Goel A, Kumar R et al. Male breast cancer: a retrospective review of clinical profile froma tertiary care center of India. South Asian I Cancer. 2017;6(4):141-3.

Rai B, Ghoshal S, Sharma SC. Breast Cancer in males: a pgimer experience. J Cancer Res Ther. 2005;1(1):31-3.

Cutuli B, Le-Nir CCS, Serin D. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol. 2010;73:246-54.

Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367:595-604.

Samuelson MH. Breast cancer: not for women only. Lancet. 2006;367:605.

Rudlowski C. Male breast cancer. Breast Care (Basel). 2008;3:183-9.

Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist. 2005;10:471-9.

Hill A, Yagmur Y, Tran KN, Bolton JS, Robson M, Borgen PI. Localized male breast carcinoma and family history. An analysis of 142 patients. Cancer. 1999;86:821-5.

McLachlan SA, Erlichman C, Liu FF. Male breast cancer: an 11-year review of 66 patients. Breast Cancer Res Treat. 1996;40:225-30.

Onami S, Ozaki M, Mortimer JE, Kumar S. Male breast cancer: an update in diagnosis, treatment and molecular profiling. Maturitas. 2010;65:308-14.

Gómez-Raposo C, ZambranaTévar F, Moyano MS, Miriam López Gómez EC. Male breast cancer. Cancer Treat Rev. 2010;36:451-7.

Joshi MG, Lee AK, Loda M. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer. 1998;77(3):490-8.

Weir J, Zhao YD, Herman T, Algan Ö. Clinicopathologic features and radiation therapy utilization in patients with male breast cancer: a national cancer database study. Breast Cancer Basic Clin Res. 2018;12:117822341877068.

Cloyd JM, Hernandez-Boussard T, Wapnir IL. Poor compliance with breast cancer treatment guidelines in men undergoing breast-conserving surgery. Breast Cancer Res Treat. 2013;139(1):177-82.

Golshan M, Rusby J, Dominguez F, Smith BL. Breast conservation for male breast carcinoma. Breast. 2007;16(6):653-6.

Goyal A, Horgan K, Kissin M, Yiangou C, Sibber-ing M, Lansdown M et al. Sentinel lymph node biopsy in male breast cancer patients. Eur J Surg Oncol. 2004;30:480-83.

Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU et al. Adjuvant systemic therapy for male breast carcinoma. Cancer. 2005;104:2359-64.